Isolation and characterization of an anti-complementary protein-bound polysaccharide from the stem barks of Eucommia ulmoides

International Immunopharmacology

Volumn 8, Issue 9, 2008, Pages 1222-1230

  Zhu, Hongwei ^a   Zhang, Yunyi ^a   Zhang, Jianwen ^b   Chen, Daofeng ^a  

^a FUDAN UNIVERSITY   (China)

^b BIOCRYST PHARMACEUTICALS INC   (United States)

Author keywords

Complement; Depleted serum; Eucommia ulmoides; Hemolysis; Inhibition; Protein bound polysaccharide

Indexed keywords

ARABINOSE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C9; EUCOMMIA ULMOIDES EXTRACT; EWDS 1; GALACTOSE; GLUCOSE; PLANT MEDICINAL PRODUCT; POLYSACCHARIDE; PROTEIN; PROTEOGLYCAN;

ANTICOMPLEMENTARY ACTIVITY; ARTICLE; BARK; BIOASSAY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; DRUG INHIBITION; DRUG ISOLATION; DRUG MECHANISM; DRUG PURIFICATION; HEMOLYSIS; HUMAN; MEDICINAL PLANT; METHYLATION; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PLANT STEM; PRIORITY JOURNAL; TU CHUNG;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATING AGENTS; ERYTHROCYTES; EUCOMMIACEAE; GUINEA PIGS; HUMANS; METHYLATION; MICE; PLANT BARK; PLANT STEMS; POLYSACCHARIDES; RABBITS; SHEEP; THROMBIN TIME;

EID: 46349095470     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.04.012     Document Type: Article

References (45)

1. Kirschfink M. Controlling the complement system in inflammation. Immunopharmacology 8 (1997) 51-62
2. Makridea S.C. Therapeutic inhibition of the complement system. Pharmacol Rev 50 (1998) 59-87
3. Lustep H.L., and Clark W.M. Current status of neuroprotective agents in the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep 1 1 (2001) 13-18
4. Peiris J.S.M., Chu C.M., Cheng V.C.C., Chan K.S., Hung I.F.N., Poon L.L.M., et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. The Lancet 361 (2003) 1767-1772
5. Xu H., Zhang Y.Y., Zhang J.W., and Chen D.F. Anti-complementary agents from natural products. Chin J Nat Med 5 5 (2007) 322-332
6. In: Xie W., Fan C., and Zhu Z. (Eds). Quan Guo Zhong Cao Yao Hui Bian (1996), People's Medical Publishing House, Beijing 423-424
7. Ge J.R., Wang H.M., Yang L.Z., Yin H.B., Feng X.H., Jiang Q., et al. IIPeriod clinical trial of compound Du Zhong Jian Gu Grain treating knee osteoarthritis. Chin J Trad Med Traum & Orthop 10 (2002) 19-23
8. Jiangsu New Medical College. Dictionary of Chinese Herbal Medicine vol. 1 (1977), Shanghai Science and Technology Publishing House, Shangha 1031-1033
9. Deyama T., Nishibe S., and Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacol Sin 22 (2001) 1057-1070
10. Tomada M., Gonda R., Shimizu N., and Kanari M. A reticuloendothelial system-activating glycan from the barks of Eucommia ulmoides. Phytochemistry 29 10 (1990) 3091-3094
11. Xu S.L., Zhou H.Q., Huang W.G., Zeng Q.Z., Liu M., and Pan Z.X. Influences of Eucommia ulmoides on nonspecific immunity of organs. Chin Tradit Herb Drugs 14 8 (1983) 27-28
12. Abe M. Complement activation and inflammation. Jpn J Clin Pathol 54 (2006) 744-756
13. Sahu A., and Lambris J.D. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics. Immunopharmacology 49 (2000) 133-148
14. Sarma V.J., Huber-Lang M., and Ward P.A. Complement in lung disease. Autoimmunity 39 (2006) 387-394
15. Oshima Y., Takata S., Hikino H., Deyama T., and Kinoshita G. Anticomplementary activity of the constituents of Eucommia ulmoides bark. J Ethnopharmacol 23 (1988) 159-164
16. Zhou J., Zhang Y.Y., Zhang J.W., Xu H., and Chen D.F. Research in Chinese traditional medicine Eucommia ulmoides Oliver of the effect on complement system. J Fudan Univ (Med Sci) 33 1 (2006) 101-106
17. Dubios M., Gilles K.A., Hamilton J.K., Rebers P.A., and Smith F. Colorimetric method for determination of sugar and related substances. Anal Chem 28 (1956) 250-256
18. Blumenkranz N., and Asboe-hansen G. New method for quantitative determination of uronic acids. Anal Biochem 54 (1973) 484-489
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
20. Craige J.S., Wen Z.C., and Meer J.P. Intraspecific and nutritionallydetermined variations in the composition of agars from Gracilaria spp. Bot Mar 27 (1981) 55-61
21. Jones T.M., and Albersheim P. A gas chromatographic method for the determination of aldose and uronic acid constituents of plant cell wall polysaccharides. Plant Physiol 49 (1972) 926-936
22. Ciucanu I., and Kerek F. A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res 131 (1984) 209-217
23. Mayer M.M. Complement and complement fixation. In: Kabat E., and Mayer M. (Eds). Experimental immunochemistry. 2nd ed. (1961), Springfield Publications 133-240
24. Klerx J.P., Beukelman C.J., Van D.H., and Willers J.M. Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J Immunol Methods 63 2 (1983) 215-220
25. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual (1982), Cold Spring Harbor Laboratory Press, NY 191
26. Stancioff D.J., and Stanley N.F. Infrared and chemical studies on algal polysaccharides. Proc Int Seaweed Symp 6 (1969) 595-609
27. Sun H.H., Wooten J.B., Ryan W.S., Bokelman J.G.H., and Aman P. Structural characterization of a tobacco rhamnogalacturonan. Carbohydr Polym 7 (1987) 143-158
28. Ali Z., Khan S.I., Fronczek F.R., and Khan I.A. 9,10-seco-9,19-cyclolanostane arabinosides from the roots of Actaea podocarpa. Phytochemistry 68 (2007) 373-382
29. Fabián B., María C.R., María C.M., and Felix C.C. Neutral polysaccharide from Cedrela tubiflora with anticomplementary activity. Phytochemistry 50 (1999) 57-62
30. León G., Lomonte B., and Gutiérrez J.M. Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols. Toxicon 45 (2005) 123-128
31. Alban S., Classen B., Brunner G., and Blaschek W. Differentiation between the complement modulating effects of an arabinogalactan-protein from Echinacea purpurea and heparin. Planta Med 68 (2002) 1118-1124
32. Tatsunori Y., Yamaguchi A., Saito T., and Seguchi M. Complement-modulating water-soluble polysaccharide fractions in two global staple cereals: rice and wheat. J Sci Food Agric 88 (2008) 805-812
33. Beuscher N., Bodinet C., Willigmann I., and Egert D. Immunmodulierende eigenschaften von wurzelextrakten verschiedener Echinacea-Arten. Z Phytother 16 (1995) 157-166
34. Lohmann-Matthes M.L., and Wagner H. Aktivierung von makrophagen durch polysaccharide aus gewebekulturen von Echinacea purpurea. Z Phytother 10 (1989) 52-59
35. Wagner H., Stuppner H., Puhlmann J., Brümmer B., Deppe K., and Zenk M.H. Gewinnung von immunologisch aktiven polysacchariden aus Echinacea-Drogen und -Gewebekulturen. Z Phytother 10 (1989) 35-38
36. Yamada H., Nagai T., Cyong J.C., Otsuka Y., Tomoda M., Shimizu N., et al. Relationship between chemical structure and anti-complementary activity of plant polysaccharides. Carbohydr Res 144 (1985) 101-111
37. Zhao Q.C., Kiyohara H., and Yamada H. Anti-complementary neutral polysaccharides from leaves of Artemisia princeps. Phytochemistry 35 (1994) 73-77
38. Kiyohara H., Zhang Y., and Yamada H. Effect of exo-β-D-(1→3)-galactanase digestion on complement activating activity of neutral arabinogalactan unit in a pectic arabinogalactan from roots of Angelica acutiloba Kitagawa. Carbohydr Polym 32 (1997) 249
39. Xu H., Zhang Y.Y., Zhang J.W., and Chen D.F. Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii. Int Immunopharmacol 7 (2007) 175-182
40. Morgan B.P., and Harris C.L. Complement therapeutics; history and current progress. Mol Immunol 40 (2003) 159-170
41. Weiler J.M., Yurt R.W., Fearon D.T., and Austen K.F. Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin. J Exp Med 147 2 (1978) 409-421
42. Weiler J.M., Edens R.E., Linhardt R.J., and Kapelanski D.P. Heparin and modified heparin inhibit complement activation in vivo. J Immunol 148 10 (1992) 3210-3215
43. Zhang Y., Kiyohara H., Matsumoto T., and Yamada H. Fractionation and chemical properties of immunomodulating polysaccharides from roots of Dipsacus asperoide. Planta Med 63 (1997) 393-399
44. Cimanga K., De B.T., Lasure A., Van P.B., Pieters L., Vanden B.D., et al. In vitro anti-complementary activity of constituents from Morinda morindoides. J Nat Prod 58 3 (1995) 372-378
45. Lee S.M., Kim J.H., Zhang Y., An R.B., Min B.S., Joung H., et al. Anticomplementary activity of protostane-type triterpenes from Alismatis rhizoma. Arch Pharm Res 26 6 (2003) 463-465